血管新生素II和EDH通路是雌性大鼠中5-HT的血管交感调节的基础
Anaïs Clara Terol-Úbeda1,2, Juan Francisco Fernández-González1,2, Asunción Morán1,2
1Laboratorio de Farmacología, Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, 37007 Salamanca, Spain.
International journal of molecular sciences
|October 16, 2025
概括
雌性大鼠表现出明显的血管血清激素 (5-HT) 交感调节. 5-HT1D途径使用内皮依赖的高极化,而5-HT2A涉及血管素II,而5-HT3没有间接途径.
科学领域:
- 心血管生理学心血管生理学
- 神经药理学神经药理学
- 血清能信号传递 血清能信号传递
背景情况:
- 血管类血清素 (5-HT) 通过各种途径调节同情性活动,包括氧化 (NO),内皮依赖高极化 (EDH) -K+通道,前列腺素,血管激素II (Ang-II) 和内皮蛋白.
- 在血清激素的交感调节方面存在显著的基于性别的差异,特别是在雌性大鼠中.
- 了解这些性别特异性机制对于理解血管平衡至关重要.
研究的目的:
- 为了研究间接途径对雌性大鼠中5-HT介导的血管交友调节的参与.
- 为了阐明5-HT1D介导的抑制和5-HT2A/3介导的强化对血管性诺亚氨基神经递质的作用.
- 在女性中确定参与这些5-HT通路的特定介质.
主要方法:
- 实验是在雌性小鼠身上进行的.
- 对NO,K+通道,前列腺素,Ang-II或内分泌物进行静脉抑制剂/阻塞剂的静脉注射.
- 输注5-HT受体激活剂 (L-694,247为5-HT1D,TCB-2为5-HT2A,1-PBG为5-HT3),然后电刺激血管交感外流以测量血管压缩反应.
主要成果:
- 5-HT1D诱导的交抑制被非选择性的K+通道阻断剂 (四乙) 取消,表明通过EDH通路进行中介.
- 洛萨坦 (Ang-II类型1受体对抗剂) 阻断了5-HT2A介导的交增强,而Ang-II水平在TCB-2输注后增加,将5-HT2A与Ang-II联系起来.
- 5-HT3诱导的同情刺激效应不受任何测试的抑制剂的影响,这表明没有间接途径的参与.
结论:
- 在雌性大鼠中,EDH通路对于5-HT1D诱导的交抑制至关重要.
- 由5-HT2A受体介导的同情刺激效应与血管新生素II有关.
- 由5-HT3受体介导的交感增强作用独立于研究的间接途径.
相关概念视频
Hypertension II: Pathophysiology
781
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
781
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Hormonal Regulation
35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
Hormonal Regulation of Blood Pressure
5.9K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.9K
Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707


